Market Place
Sourcing Support
Finch Announces Delisting from Nasdaq and SEC Deregistration
21 Oct 2024 //
GLOBENEWSWIRE
Finch Announces Reverse Stock Split of Common Stock
09 Jun 2023 //
GLOBENEWSWIRE
Finch Therapeutics Reports 1Q 2023FYR &Provides Business Updates
10 May 2023 //
GLOBENEWSWIRE
Finch continues to pinch pennies to stretch cash into 2025
24 Mar 2023 //
FIERCE BIOTECH
Finch Therapeutics 4Q & 2022 FYR and Provides Business Updates
23 Mar 2023 //
GLOBENEWSWIRE
Finch stops phase 3, lays off 95% of staff and plans asset sale
25 Jan 2023 //
FIERCE BIOTECH
Finch Therapeutics Provides Corporate Updates 3Q 2022 Financial Results
10 Nov 2022 //
GLOBENEWSWIRE
Finch Therapeutics to Present at the Jefferies London Healthcare Conference
09 Nov 2022 //
GLOBENEWSWIRE
Finch Therapeutics Presents PRISM-EXT Biomarker Data at ACG 2022
24 Oct 2022 //
GLOBENEWSWIRE
Finch cutting its workforce days after Takeda clips its fiscal wings
02 Sep 2022 //
FIERCEBIOTECH
Finch Therapeutics Regains Rights to Two Takeda-Owned IBD Drugs
27 Aug 2022 //
BIOSPACE
Finch Regains Full Rights to FIN-524 and FIN-525 Targeted Microbiome Candidates
25 Aug 2022 //
GLOBENEWSWIRE
Finch Tx to Present at the H.C. Wainwright Global Investment Conference
17 May 2022 //
GLOBENEWSWIRE
Finch Therapeutics Reports First Quarter 2022 Financial Results
16 May 2022 //
GLOBENEWSWIRE
Finch Therapeutics to Host Corporate Update Conference Call
09 May 2022 //
GLOBENEWSWIRE
Finch Therapeutics Gets FDA Green Light to Resume CDI Therapy Trial
30 Apr 2022 //
BIOSPACE
Finch`s nest thins out: 20% of employees cut in restructuring
20 Apr 2022 //
FIERCEBIOTECH
Finch clips wings of hep B program, pausing clinical push
02 Apr 2022 //
FIERCEBIOTECH
Finch Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
31 Mar 2022 //
GLOBENEWSWIRE
Finch Tx Provides Update on Phase 3 Trial of CP101 in Recurrent C. difficile
01 Mar 2022 //
GLOBENEWSWIRE
Finch Therapeutics to Participate in the Chardan Medicines Summit
23 Feb 2022 //
GLOBENEWSWIRE
Finch Therapeutics Announces Additions to Senior Leadership Team
10 Feb 2022 //
GLOBENEWSWIRE
Finch Receives Two New U.S. Patents for FIN-211 in Autism Spectrum Disorder
06 Jan 2022 //
GLOBENEWSWIRE
Finch to Present at two Conferences
04 Jan 2022 //
GLOBENEWSWIRE
Finch Therapeutics Appoints Joseph Vittiglio as Chief Business and Legal Officer
20 Dec 2021 //
GLOBENEWSWIRE
Finch Therapeutics Announces Positive Topline Results from PRISM-EXT
09 Nov 2021 //
GLOBENEWSWIRE
Finch Therapeutics Presents Positive Data from PRISM3 Clinical Trial of CP101
25 Oct 2021 //
GLOBENEWSWIRE
Finch Therapeutics Appoints Marc Blaustein as Chief Operating Officer
08 Sep 2021 //
GLOBENEWSWIRE
Finch Therapeutics Added to Russell 2000 and Russell 3000 Indexes
28 Jun 2021 //
GLOBENEWSWIRE
Three drugmakers nab $639M as biotech`s IPO pace eclipses a record year
20 Mar 2021 //
BIOPHARMADIVE
Finch Therapeutics Presents Data from Its Positive PRISM3 Trial of CP101
28 Oct 2020 //
BIOSPACE
Finch Presents Data from Its Positive PRISM3 Trial of CP101 in Recurrent
27 Oct 2020 //
BUSINESSWIRE
Finch Therapeutics to Present Data from its Positive PRISM3 Trial of CP101
09 Oct 2020 //
BUSINESSWIRE
Finch Closes $90 Million Series D to Advance C. Difficile Infection Product
17 Sep 2020 //
BIOSPACE
Finch Therapeutics Announces $90 Million Financing to Advance Pipeline
17 Sep 2020 //
BUSINESSWIRE
Finch nets $90M to push med toward FDA filing, move into hep B, autism
17 Sep 2020 //
FIERCE BIOTECH
Finch Therapeutics Announces $90 Million Financing to Advance Pipeline
16 Sep 2020 //
BUSINESSWIRE
In big year for microbiome drugs, a small biotech sets the bar
20 Jun 2020 //
BIOPHARMADIVE
Finch Announces Topline Results from Randomized Controlled Trial of CP101
19 Jun 2020 //
BUSINESS WIRE
Finch Therapeutics` microbiome med quells stubborn C. difficile
18 Jun 2020 //
FIERCE BIOTECH
Finch Therapeutics Announces Results from Randomized Controlled Trial of CP101
18 Jun 2020 //
BUSINESS WIRE
Finch Therapeutics Completes Enrollment in Potentially Pivotal Trial of CP101
08 Jan 2020 //
BUSINESS WIRE
Finch Therapeutics Completes Enrollment in Potentially Pivotal Trial of CP101
08 Jan 2020 //
BUSINESS WIRE
Finch Therapeutics Completes Enrollment in Potentially Pivotal Trial of CP101
07 Jan 2020 //
BUSINESS WIRE
Finch Therapeutics & Takeda Expand Collaboration to Develop Microbiome
13 Nov 2019 //
BUSINESSWIRE
Takeda doubles down on Finch`s microbiome insights, signing up
13 Nov 2019 //
ENDPTS
Artizan completes microbiome starter package with Brii deal
10 Jun 2019 //
ENDPTS
Finch`s Receives Fast Track for the Investigation of Full-Spectrum Microbiota
29 Apr 2019 //
BUSINESSWIRE
Genentech and Microbiotica Ink Multi-Year Collaboration Deal
06 Jun 2018 //
BIOSPACE
Takeda-partnered Finch Therapeutics grabs $36M and looks to leapfrog
01 Mar 2018 //
ENDPTS
